Search Results 1071-1080 of 18714 for hepatitis

  1. Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies - Mayo Clinic

    hepatitis B core antibody [anti-HBc] and absence of HBsAg) are eligible ... positive for hepatitis C (HCV) antibody are eligible only if polymerase chain reaction

  2. MEDI5752 In Combination With Carboplatin Plus Pemetrexed In Unresectable Pleural Mesothelioma - Mayo Clinic

    * History of another primary malignancy with exceptions. * Uncontrolled intercurrent illness * Tuberculosis, hepatitis B (HBV) or hepatitis C (HCV), human ...

  3. Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma - Mayo Clinic

    Participants with a positive total hepatitis (Hep) B core antibody and negative hepatitis B virus surface antigen (HBsAg) at screening are at high risk for ...

  4. A Study of Axatilimab at 3 Different Doses in Patients With Chronic Graft Versus Host Disease (cGVHD) - Mayo Clinic

    Hepatitis C (defined as positive hepatitis C [HCV] antibody with positive HCV ribonucleic acid [RNA]). 8. Diagnosed with another malignancy (other than ...

  5. A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia - Mayo Clinic

    ... Hepatitis B core antigen (anti-HBc) and/or antibodies to hepatitis B surface antigen (anti-HBs) must be screened using real-time polymerase chain reaction ...

  6. Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation - Mayo Clinic

    Has a positive test for human immunodeficiency virus (HIV-1 or -2) hepatitis C virus (HCV) or hepatitis B surface antigen (HBsAg); Receiving chronic systemic ...

  7. A Study to Assess Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Elastography - Mayo Clinic

    ... hepatitis B core antigen, anti-HBc total, are not excluded). Evidence of chronic hepatitis C as marked by the presence of anti-HCV or HCV RNA in serum. Low ...

  8. Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004) - Mayo Clinic

    * Concurrent active Hepatitis B (defined as HBsAg positive and/or detectable HBV DNA) and Hepatitis C virus (defined as anti-HCV Ab positive and detectable ...

  9. Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy - Mayo Clinic

    Patients must be tested for hepatitis B virus (HBV), hepatitis B surface antigen (HBsAg+) and hepatitis C (HCV) antibody within 6 weeks of registration.

  10. Infliximab-qbtx (intravenous route) - Side effects & uses - Mayo Clinic

    Hepatitis B, active or history of or; Histoplasmosis (fungus infection) ... This medicine may increase your chance of having a lupus-like syndrome or a liver ...